Protection against RSV among infants and birthing parents differed by race and ethnicity, indicating the need to ensure equitable access to RSV products.

Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in ...

The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.

A new antibody shot could help infants who contract respiratory ... significant lasting difference in what RSV, how it impacts our community." The treatment is also recommended for older adults ...

Most treatments are supportive ... RSV disease Pregnant women during weeks 32-36 of pregnancy Infants can be protected from RSV early in life with an RSV antibody given soon after they're born.

Coinfection with RSV, REV, and MPV was significantly associated with treatment failure and prolonged treatment in children with viral LRTIs on respiratory support.

With millions of cases annually worldwide, especially among infants under six months, RSV imposes a significant burden on families and healthcare systems. Current treatments are limited to ...

ATLANTA (AP) — A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new ...

The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the ...